This article was originally published in the Georgetown Journal of International Law
In response to mounting concerns regarding the impact of biopiracy, the Nagoya Protocol presents a promising opportunity to address the concerns surrounding indigenous rights in the psychedelic industry.
The psychedelic industry is experiencing a “renaissance,” with novel therapies and medicinal breakthroughs capturing widespread attention. According to psychiatrist and consciousness researcher Stanislov Grof, psychedelics, when “used responsibly and with proper caution, would be for psychiatry what the microscope is to the study of biology and medicine or the telescope for astronomy.” From the exploration of psilocybin-assisted therapy for mental health disorders to the investigation of ibogaine as a potential treatment for addiction, researchers and entrepreneurs are tapping into the therapeutic potential of psychedelic substances in unprecedented ways.
However, amidst this wave of innovation, concerns have emerged regarding the treatment of indigenous communities. Despite their traditional knowledge serving as the foundation for many of these developments, there is growing concern that the communities are being left behind or exploited. As the psychedelic ecosystem continues to evolve, it is imperative to address these concerns and ensure that indigenous communities are properly consulted, respected, and compensated for their contributions.
Read the full text of this article at law.georgetown.edu
